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In Response: We agree with Ringwald and Dondorp (1)
that our report of a Vietnamese worker returning from An-
gola with severe Plasmodium falciparum malaria not respon-
sive to artemisinins (2) is unlikely to indicate that artemisinin 
resistance has reached Angola. Nevertheless, this case, for its 
unusual clinical manifestation and response to treatment, had 
raised alarm in Vietnam, where the number of imported ma-
laria cases and deaths among Vietnamese workers returning 
from Africa has recently increased (3,4). After our report was 
published in July 2014, we collected additional information 
that may be useful in putting such a case in perspective. 
The results of an external quality control study by Sig-
ma-Tau Pharmaceuticals on 10 vials of the same batch (no. 
511002) of intravenous artesunate as administered to our 
case-patient (report available on request) confirmed accept-
able drug concentration and showed that the opalescence ob-
served after reconstitution was caused by precipitation of an 
impurity (representing 0.12% of the preparation) identified 
as an active metabolite of artesunate. Therefore, the treat-
ment administered to the patient was of acceptable quality. 
The blood concentrations of artesunate and dihydroartemis-
inin may have been 20% lower than ideal (as predicted by a 
pharmacokinetic model), but this finding cannot explain why 
the parasite density remained >200,000/μL for several days.
Ringwald and Dondorp also mention functional asple-
nia as a possible cause of delayed parasite clearance. We ar-
gue that this would have resulted in a much longer (weeks/
months) parasite clearance (5) than the observed sharp de-
crease after quinine and tetracycline administration. More-
over, we did not observe any accumulation of circulating 
dead parasites (Howell-Jolly bodies), which is against the hy-
pothesis of functional asplenia. Furthermore, sharp decline of 
parasite density immediately after quinine and doxycycline 
administration by nasogastric tube is not consistent with the 
proposed hypothesis of reduced intestinal absorption.
In hindsight and after consideration of additional in-
formation, we agree that it is unlikely this patient harbored 
several resistant parasite clones. However, the reasons for 
the lack of response to arteminins in this patient remain 
unknown and are under continued investigation.
The discussion triggered by the publication of our 
case report raises the question of what should be report-
ed to the attention of the scientific community and pub-
lic health authorities. Besides being an obligation for 
clinical physicians, reporting unusual treatment failures 
such as our case is also an essential component of anti-
malarial resistance surveillance. As mentioned by Ring-
wald and Dondorp, “vigilant monitoring is pivotal” for 
the detection of possible foci of resistance. For early de-
tection of artemisinin resistance, we would rather have a 
more sensitive than specific system, because the latter 
would probably miss the first emerging cases of resistance. 
Reporting cases similar to the one we published should 
be encouraged.
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